Groups
Conversations
All groups and messages
Send feedback to Google
Help
Training
Sign in
Groups
Type-1 Diabetes Clinical Trials News
Conversations
About
Type-1 Diabetes Clinical Trials News
Contact owners and managers
1–30 of 278
Mark all as read
Report group
0 selected
joshua levy
Mar 8
Levicure's Combination Therapy
Levicure is a startup which is currently raising money to fund a phase-II trial for a combination
unread,
Levicure's Combination Therapy
Levicure is a startup which is currently raising money to fund a phase-II trial for a combination
Mar 8
joshua levy
Jan 30
Results from a Phase-IIΔ Trial of Pleconaril and Ribavirin
This clinical trial represents an attack on T1D slightly different than anything I've blogged on
unread,
Results from a Phase-IIΔ Trial of Pleconaril and Ribavirin
This clinical trial represents an attack on T1D slightly different than anything I've blogged on
Jan 30
joshua levy
Jan 22
Results From A Phase-IIΔ Baricitinib (Olumiant)
Baricitinib (trade name Olumiant) is a drug which targets the immune system, and is already approved
unread,
Results From A Phase-IIΔ Baricitinib (Olumiant)
Baricitinib (trade name Olumiant) is a drug which targets the immune system, and is already approved
Jan 22
joshua levy
Jan 6
What To Watch In 2024
At the start of a new year, some bloggers write a posting on the year that was, and a some write a
unread,
What To Watch In 2024
At the start of a new year, some bloggers write a posting on the year that was, and a some write a
Jan 6
joshua levy
12/24/23
Diamyd Update
This is my first update on the Diamyd company in many, many years. It is focused on their DIAGNODE-3
unread,
Diamyd Update
This is my first update on the Diamyd company in many, many years. It is focused on their DIAGNODE-3
12/24/23
joshua levy
12/16/23
Islet Cell Transplantation Clinical Trails
In this blog I'm going to report on three different clinical trials involving transplantation.
unread,
Islet Cell Transplantation Clinical Trails
In this blog I'm going to report on three different clinical trials involving transplantation.
12/16/23
joshua levy
11/28/23
Teplizumab/Tzield Reports Results From A Phase-III in Honeymooners (PROTECT)
Teplizumab (sold as Tzield) was recently approved for use in people at-risk of diagnosis for T1D. At
unread,
Teplizumab/Tzield Reports Results From A Phase-III in Honeymooners (PROTECT)
Teplizumab (sold as Tzield) was recently approved for use in people at-risk of diagnosis for T1D. At
11/28/23
joshua levy
11/11/23
JDRF Funding for a Cure 2023
In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation)
unread,
JDRF Funding for a Cure 2023
In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation)
11/11/23
joshua levy
10/9/23
DFMO Starts A Phase-II Clinical Trial (TADPOL)
Difluoromethylornithine (DFMO), also known as Eflornithine, is FDA approved since 1990 as an
unread,
DFMO Starts A Phase-II Clinical Trial (TADPOL)
Difluoromethylornithine (DFMO), also known as Eflornithine, is FDA approved since 1990 as an
10/9/23
joshua levy
9/21/23
Strong Results from a Pilot Study of Semaglutide in Adult Honeymooners
I've been blogging on research aimed at curing type-1 diabetes for over 15 years, and in that
unread,
Strong Results from a Pilot Study of Semaglutide in Adult Honeymooners
I've been blogging on research aimed at curing type-1 diabetes for over 15 years, and in that
9/21/23
joshua levy
7/31/23
T1D Research News (Quick Bits for July)
This blog is a collection of smaller news items about T1D. COVID Not Likely to Increase T1D in
unread,
T1D Research News (Quick Bits for July)
This blog is a collection of smaller news items about T1D. COVID Not Likely to Increase T1D in
7/31/23
joshua levy
6/12/23
CELZ-201 Starts a Phase-I Trial (CREATE-1)
CELZ-201 is a stem cell product, where the cells are isolated from the umbilical cord, Wharton's
unread,
CELZ-201 Starts a Phase-I Trial (CREATE-1)
CELZ-201 is a stem cell product, where the cells are isolated from the umbilical cord, Wharton's
6/12/23
joshua levy
5/9/23
Dompé Starts GLADIATOR, a Phase-III Clinical Trial of Ladarixin
Ladarixin is a drug being develop by Dompé (an Italian company). It inhibits activity on parts of the
unread,
Dompé Starts GLADIATOR, a Phase-III Clinical Trial of Ladarixin
Ladarixin is a drug being develop by Dompé (an Italian company). It inhibits activity on parts of the
5/9/23
joshua levy
4/7/23
T1D Research News (Quick Bits from April)
This blog covers three pieces of news which do not apply directly to cure focused research, but which
unread,
T1D Research News (Quick Bits from April)
This blog covers three pieces of news which do not apply directly to cure focused research, but which
4/7/23
joshua levy
3/31/23
Results from a Phase-II Verapamil Study
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and
unread,
Results from a Phase-II Verapamil Study
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and
3/31/23
joshua levy
3/20/23
Influenza Vaccination Starts a Phase-II? Clinical Trial
This is a straight forward clinical trial: people recently diagnosed with type 1 diabetes (in their
unread,
Influenza Vaccination Starts a Phase-II? Clinical Trial
This is a straight forward clinical trial: people recently diagnosed with type 1 diabetes (in their
3/20/23
joshua levy
2/27/23
Ixekizumab (Taltz) Starts a Phase-II? Trial In Honeymooners
Ixekizumab, sold under the trade name Taltz, blocks a specific part of the immune system called
unread,
Ixekizumab (Taltz) Starts a Phase-II? Trial In Honeymooners
Ixekizumab, sold under the trade name Taltz, blocks a specific part of the immune system called
2/27/23
joshua levy
2/9/23
OPT101 Starts A Phase-I Trial in Adults with Established T1D
OPT101 is a peptide derived from mouse CD154. What does that mean? A peptide is a small part of a
unread,
OPT101 Starts A Phase-I Trial in Adults with Established T1D
OPT101 is a peptide derived from mouse CD154. What does that mean? A peptide is a small part of a
2/9/23
joshua levy
12/26/22
Youtube Video Describing How JDRF Makes Funding Decisions
If you care about research aimed at curing type-1 diabetes, then you should care about JDRF's
unread,
Youtube Video Describing How JDRF Makes Funding Decisions
If you care about research aimed at curing type-1 diabetes, then you should care about JDRF's
12/26/22
joshua levy
12/16/22
ASDCC Starts Phase-I Clinical Trial of Extracorporeal Photopheresis (Opera)
This is a phase-I, 10 person trial which started in September 2022, and is expected to finish in
unread,
ASDCC Starts Phase-I Clinical Trial of Extracorporeal Photopheresis (Opera)
This is a phase-I, 10 person trial which started in September 2022, and is expected to finish in
12/16/22
joshua levy
12/3/22
The FDA Approves Teplizumab Under The Name TZIELD™ (teplizumab-mzwv)
On 17-Nov-2022, The USA FDA approved Teplizumab. This is the first drug ever approved in the United
unread,
The FDA Approves Teplizumab Under The Name TZIELD™ (teplizumab-mzwv)
On 17-Nov-2022, The USA FDA approved Teplizumab. This is the first drug ever approved in the United
12/3/22
joshua levy
11/16/22
Results from MultiPepT1De (Multi Peptide Vaccine) by Powrie at King’s College London
This is the most recent result from a long line of research led by Colin Dayan and Mark Peakman, at
unread,
Results from MultiPepT1De (Multi Peptide Vaccine) by Powrie at King’s College London
This is the most recent result from a long line of research led by Colin Dayan and Mark Peakman, at
11/16/22
joshua levy
10/16/22
JDRF Funding for a Cure 2022
In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation)
unread,
JDRF Funding for a Cure 2022
In the US, we are in the "Walking Season" when JDRF (Juvenile Diabetes Research Foundation)
10/16/22
joshua levy
9/16/22
Research Dropped As A Practical Cure
Every year I have the sad job of removing some projects from my list of active research aimed at
unread,
Research Dropped As A Practical Cure
Every year I have the sad job of removing some projects from my list of active research aimed at
9/16/22
joshua levy
7/11/22
Provention Bio Update
Provention Bio is a small biotech company targeting several autoimmune diseases. It has two drug
unread,
Provention Bio Update
Provention Bio is a small biotech company targeting several autoimmune diseases. It has two drug
7/11/22
joshua levy
5/4/22
NN1845 (a glucose sensitive insulin) Starts A Second Phase-1 Clinical Trail
One approach to creating a "practical cure" for T1D is sometimes called "smart insulin
unread,
NN1845 (a glucose sensitive insulin) Starts A Second Phase-1 Clinical Trail
One approach to creating a "practical cure" for T1D is sometimes called "smart insulin
5/4/22
joshua levy
4/5/22
ViaCyte and CRISPR start a Phase-I Clinical Trial (VCTX210A-101)
For many years, it has been clear that one possible path to a cure is to transplant new beta cells
unread,
ViaCyte and CRISPR start a Phase-I Clinical Trial (VCTX210A-101)
For many years, it has been clear that one possible path to a cure is to transplant new beta cells
4/5/22
joshua levy
3/21/22
Update On Teplizumab from Provention Bio
Teplizumab is a proposed treatment which, if given to someone at-risk for type-1 diabetes (T1D), can
unread,
Update On Teplizumab from Provention Bio
Teplizumab is a proposed treatment which, if given to someone at-risk for type-1 diabetes (T1D), can
3/21/22
joshua levy
2/16/22
Verapamil SR Starts A Phase-II Trial (Ver-A-T1D)
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and
unread,
Verapamil SR Starts A Phase-II Trial (Ver-A-T1D)
Verapamil is a drug which has been used in the US since 1982 for high blood pressure, migraines, and
2/16/22
joshua levy
1/13/22
No One Was Cured Of Type-1 Diabetes in 2021
You might have seen a headline like one of these: Ohio man appears to be first in the world to be
unread,
No One Was Cured Of Type-1 Diabetes in 2021
You might have seen a headline like one of these: Ohio man appears to be first in the world to be
1/13/22